Newsroom
Company
Nanyang Biologics at GITEX ASIA SINGAPORE 2025
Nanyang Biologics will be joining GITEX ASIA – Asia’s largest and most global tech, startup, and digital investment event – taking place from April 23 to 25 at Marina Bay Sands, Singapore.
April 18, 2025
Company
Nanyang Biologics - NTU Joint Laboratory
A pioneering collaboration with Nanyang Technological University Singapore with the NYB - NTU Joint Laboratory, aiming at revolutionizing drug discovery through the power of AI and natural compounds.
Partnership
Nanyang Biologics Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
Nanyang Biologics is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Publications
Publication of DTIGN on IEEE Xplore
Advancing Bioactivity Prediction Through Molecular Docking and Self-Attention.
Company
Unlocking Nature’s Potential for Breakthrough Therapies with DTIGN
Nanyang Biologics' AI-driven DTIGN platform revolutionizes natural compound drug discovery with great accuracy, efficiency, and speed, unlocking nature's vast therapeutic potential for breakthrough treatments.
Partnership
Nanyang Biologics Joins Prestigious Johnson & Johnson Innovation JLABS to Accelerate AI-Driven Drug Discovery
Nanyang Biologics becomes a resident company of JLABS, joining a global network dedicated to accelerating life-enhancing health and wellness solutions.
Partnership
Nanyang Biologics Joins NVIDIA & Tribe’s Prestigious Ignition Program
Nanyang Biologics harnesses NVIDIA AI and accelerated computing to transform $7 billion drug discovery industry.
No items found.
No items found.
Company
Nanyang Biologics at GITEX ASIA SINGAPORE 2025
Nanyang Biologics will be joining GITEX ASIA – Asia’s largest and most global tech, startup, and digital investment event – taking place from April 23 to 25 at Marina Bay Sands, Singapore.
Company
Nanyang Biologics - NTU Joint Laboratory
A pioneering collaboration with Nanyang Technological University Singapore with the NYB - NTU Joint Laboratory, aiming at revolutionizing drug discovery through the power of AI and natural compounds.
Company
Unlocking Nature’s Potential for Breakthrough Therapies with DTIGN
Nanyang Biologics' AI-driven DTIGN platform revolutionizes natural compound drug discovery with great accuracy, efficiency, and speed, unlocking nature's vast therapeutic potential for breakthrough treatments.
Partnership
Nanyang Biologics Joins NVIDIA GTC 2025: Advancing AI in Drug Discovery
Nanyang Biologics is revolutionizing drug discovery with AI at NVIDIA GTC 2025! Discover how we’re using the latest technologies to accelerate life-saving innovations.
Partnership
Nanyang Biologics Joins Prestigious Johnson & Johnson Innovation JLABS to Accelerate AI-Driven Drug Discovery
Nanyang Biologics becomes a resident company of JLABS, joining a global network dedicated to accelerating life-enhancing health and wellness solutions.
Partnership
Nanyang Biologics Joins NVIDIA & Tribe’s Prestigious Ignition Program
Nanyang Biologics harnesses NVIDIA AI and accelerated computing to transform $7 billion drug discovery industry.
No items found.
Publications
Publication of DTIGN on IEEE Xplore
Advancing Bioactivity Prediction Through Molecular Docking and Self-Attention.
